MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF
MSC-NTF-002-HMO-CTIL
Phase 2 mab completed
Quick answer
MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF for Amyotrophic Lateral Sclerosis is a Phase 2 program (mab) at BRAINSTORM CELL THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRAINSTORM CELL THERAPEUTICS INC.
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed